Teva Pharmaceutical Industries Ltd. (TEVA) Friday said it launched an authorized generic of Actoplus Met, or pioglitazone/metformin tablets, in US.
Actoplus met is marketed by Takeda Pharmaceuticals U.S.A Inc. and used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. Actoplus met had annual sales of about $413 million in the US, based on IMS sales data as of June 30, 2012.
For comments and feedback contact: editorial@rttnews.com
Business News
December 19, 2025 15:10 ET U.S. inflation data and interest rate decisions by major central banks were the highlights of this busy week for economics news flow. Employment data and survey results on the housing markets also gained attention in the U.S. In Europe, the European Central Bank and Bank of England announced their policy decisions and macroeconomic projections.